---
figid: PMC5601171__oncotarget-08-60684-g003
figlink: /pmc/articles/PMC5601171/figure/F3/
number: Figure 3
caption: (A) The non-canonical activation of GLI-1/2 through Rack1 kinase has recently
  been described, bypassing pathway activation deficiencies through the binding of
  the SHH ligand to the PTCH receptor. (B) Through the canonic activation mechanism
  of the Hh pathway, diverse strategies have been designed to achieve the selective
  inhibition of the SMO protein. The patented molecules have been employed to generate
  a downstream inhibition of the Hh pathway, through the use of these compounds new
  pre-clinical and clinical trials have been developed, contributing to the survival
  increase of patients diagnosed with diverse epithelial type neoplasms.
pmcid: PMC5601171
papertitle: 'The Hedgehog-GLI pathway in embryonic development and cancer: implications
  for pulmonary oncology therapy.'
reftext: Leonel Armas-López, et al. Oncotarget. 2017 Sep 1;8(36):60684-60703.
pmc_ranked_result_index: '3192'
pathway_score: 0.9321375
filename: oncotarget-08-60684-g003.jpg
figtitle: 'Hedgehog-GLI pathway in embryonic development and cancer: implications
  for pulmonary oncology therapy'
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5601171__oncotarget-08-60684-g003.html
  '@type': Dataset
  description: (A) The non-canonical activation of GLI-1/2 through Rack1 kinase has
    recently been described, bypassing pathway activation deficiencies through the
    binding of the SHH ligand to the PTCH receptor. (B) Through the canonic activation
    mechanism of the Hh pathway, diverse strategies have been designed to achieve
    the selective inhibition of the SMO protein. The patented molecules have been
    employed to generate a downstream inhibition of the Hh pathway, through the use
    of these compounds new pre-clinical and clinical trials have been developed, contributing
    to the survival increase of patients diagnosed with diverse epithelial type neoplasms.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GLI3
  - MAP2K1
  - CCND1
  - CCND2
  - GLI1
  - GLI2
  - MAP2K2
  - GLA
  - MTOR
  - PIK3CG
  - PRKD3
  - PRKCA
  - PIK3CD
  - PRKCB
  - PIK3R3
  - SHH
  - CCND3
  - AKT2
  - CSNK2A1
  - NFKB1
  - CSNK2B
  - PRKCZ
  - PTCH1
  - RACK1
  - ABCG2
  - AKT3
  - SMO
  - SOX2
  - CSNK2A2
  - PRKCQ
  - AKT1
  - PRKCH
  - PIK3R5
  - PRKCI
  - FOXM1
  - PIK3R6
  - PRKCE
  - PRKCG
  - PRKCD
  - PIK3CB
  - CCNE2
  - PIK3CA
  - CCNE1
  - PIK3R4
  - AZD8542
  - IPI-926
  - Cancer
genes:
- word: GLI3
  symbol: GLI3
  source: hgnc_symbol
  hgnc_symbol: GLI3
  entrez: '2737'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: CYCLIND,E
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CYCLIND,E
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: GLI1-2
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: GLI2
  symbol: GLI2
  source: hgnc_symbol
  hgnc_symbol: GLI2
  entrez: '2736'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: GLA
  symbol: GLA
  source: hgnc_symbol
  hgnc_symbol: GLA
  entrez: '2717'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: SHH
  symbol: SHH
  source: hgnc_symbol
  hgnc_symbol: SHH
  entrez: '6469'
- word: CYCLIND,E
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Ck2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A1
  entrez: '1457'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Ck2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2B
  entrez: '1460'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PTCH1
  symbol: PTCH1
  source: hgnc_symbol
  hgnc_symbol: PTCH1
  entrez: '5727'
- word: RACK1
  symbol: RACK1
  source: hgnc_symbol
  hgnc_symbol: RACK1
  entrez: '10399'
- word: ABCG2
  symbol: ABCG2
  source: hgnc_symbol
  hgnc_symbol: ABCG2
  entrez: '9429'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ŠMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: SOX2
  symbol: SOX2
  source: hgnc_symbol
  hgnc_symbol: SOX2
  entrez: '6657'
- word: Ck2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A2
  entrez: '1459'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: FOXM1
  symbol: FOXM1
  source: hgnc_symbol
  hgnc_symbol: FOXM1
  entrez: '2305'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: CYCLIND,E
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: CYCLIND,E
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals:
- word: AZD8542
  source: MESH
  identifier: C000591817
- word: IPI-926
  source: MESH
  identifier: C541444
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
